Update

Quote

Wall Street Grinder

Guest
First off my thoughts to the Pernix employees going through a lot of unknown anxiety at this point. I understand this is your profession and most have families to support. I do not take this lightly. But keep in mind the good hard working employees will always be in demand either with Pernix (if they turn things around - or with any other Pharma company).

As for investors (especially those on Stock Twits who are also freaking out now with anxiety for following all of the pumpers on the site)..... If you can take a small loss, do so. As this company has much more negatives going for it (from an investors standpoint) than positives

Example : Poor financials. I mean really poor financials. Sales decreasing each quarter, heavy debt and very little cash on hand. Plus major institutions have been selling and exiting (see Morgan Stanley and many other smaller hedge funds). The stock price you see now reflects the true worth of the company today.

Each of you are only HOPING for a buyout based on what you want to believe. Hope is not an investment strategy.

Now if you are stuck BIG already in this company (like I am with 100K shares long). this becomes a poker hand where you must play "pot odds"

There may be a 7-1 chance that this company gets bought out at lets say $3 (you can determine whatever odds of buyout you like - doesn't have to be 7-1)

So If I am risking $50K to win $450K this becomes a profitable stock for me to hold, As I am getting 9-1 odds on my 7-1 odds bet... Yes it is gambling but with some math strategy behind it.

So in conclusion, The Grinder feels it is a 7-1 long shot that the company gets bought out based on all the facts and financials presented on this company. I am stuck with 100K shares long and at this moment will stay in this stock.

But if I just bought into this stock for a lot less shares, I would be selling and moving on to better looking stocks.

The WS Grinder
 












Pernix Therapeutics Holdings Inc (NASDAQ: PTX)

Pernix Therapeutics has been an incredibly interesting stock to watch as of late, and for good reason. The stock is incredibly unique. While it’s rare to see institutional investors surrounding a penny stock, this one is breaking the norm. With solid data recently released, the company is gaining attention from investors of all walks of life. Today, we’ll talk about the data that was released, the institutions that are investing in the stock, and what we can expect to see from PTX moving forward.

PTX Is Gaining Ground With Zolpidem
The most recent positive data that was released surrounding Pernix Therapeutics was data surrounding a clinical study. The Phase IV clinical study looking into a comparison in Silenor 6mg and zolpidem 10mg. Through the stuy, the company found that its treatment, Silenor 6mg was a statistically superior treatment based on measures of arousability, gait, balance, and memory. In a statement, John Sedor, Chariman and CEO at PTX had the following to offer…

“The result of this head-to-head study further support certain key benefits of Silenor 6mg. Pernix is encouraged by these data and the impact they could have on the sleep community and patients.”

The statement above was followed by Heith Durrence, Ph.D., Sleep Expert and Medical Director of PTX…

“One of the most interesting findings in the study was that a majority of the subjects in the zolpidem group did not wake up until they were exposed to noise of at least 110 decibels… The awakening threshold data indicate that subjects taking zolpidem could have difficulty waking up to noises similar to a jackhammer, a potentially serious issue.”

Institutional Investors Love This Penny Stock
As mentioned above, it’s rare to see institutional investors interested in a penny stock. However, in this particular case, they seem to love Pernix Therapeutics.In fact, billionaire Steve Cohen recently added to his position in the company. Not to mention, 124 other institutional investors have made investments in the stock. Some of them include Morgan Stanley, Broadfin Capital, Stonepine Capital Management, venBio Select Advisor, Elk Creek Partners, Vanguard, BlackRock, and Aisling Capital.

What We Can Expect To See From PTX Moving Forward
Moving forward, I have an overwhelmingly bullish opinion of what we can expect to see from Pernix Therapeutics stock. The reality is that while institutional investors normally do not invest in penny stocks, they seem to be on something here. With so many institutions involved, it’s hard to ignore the validity in the statement that PTX has plenty of upside potential.

At the moment, the company is making big moves when it comes to sleep treatments, and that is a massive market. As the company continues to expand its findings, we’re likely to see incredible gains in approvals and sales surrounding its treatment. All in all, PTX seems to be headed for gains.

What Do You Think?
Joshua Rodriguez is the founder of CNA Finance. His writing has been featured on Investing.com, Yahoo Finance, Talk Markets, USNews & World Report, and more. To connect with Joshua, reach out to him on Google+!
 






To the poster at .51 (80K shares). You are in great shape to make money on the next spike of any decent news. I would then sell off half of your shares at say .60 to lock in some profits. And see where the stock is going from there. If it drops back to say .55 , I would sell. If it continues up, ride the wave.

I could be wrong but I do not see BK in near future and do not see a buyout anytime before August. But again, I am not an insider and could be wrong here.
 






EWhy Biotech is Getting Crushed

By Ben Levisohn
Biotech stocks like Amgen (AMGN), Celgene (CELG), Biogen (BIIB), Pernix (PTX) and Regeneron Pharmaceuticals (REGN) are getting crushed this week on worries that government regulators could propose limits on Medicare drug spending. Evercore ISI’s Mark Schoenebaum explains:

ON-BS104_PharmF_D_20160525122300.jpg

Photo: Pixabay
It has come to our attention that the IPAB determination may be announced at Brookings on Thursday. The Independent Payment Advisory Board (IPAB) is an independent executive committee intended to contain Medicare spending growth by proposing CMS reforms to be implemented by the U.S. Department of Health and Human Services. The IPAB is “triggered” (comes into existence) when the actual growth rate exceeds a target growth rate set by the CMS actuary. Although IPAB can propose reforms to any portion of CMS spending, we do not believe that the IPAB will target Part D drug spending specifically.

Drug spending is an unlikely target. Outpatient prescription drug spending (e.g. Part D) accounted for 11% of 2014 Medicare benefit payments. Hospital inpatient services (23%), Medicare Advantage (26%), and other services including dialysis (14%) are bigger contributors to overall spending. Historical targets have included reductions in payments to plans and providers coupled with delivery reform under the Affordable Care Act and 2011 Budget Control Act. Neither the ACA nor HHS has the authority to regulate drug prices.

There are limits to what IPAB can do. (1) The IPAB is not allowed to cut payments to hospitals until 2018; (2) the magnitude of cuts the IPAB can propose is capped: 1% of CMS outlays in 2016, 1.25% in 2017, and 1.5% in 2018 and beyond.
 
Last edited by a moderator:






Hey wall Street idiot... if you have 100k shares and your investment is $50k since the Co ducks so much you can get out now and only lose $1k you are not stuck. You are just an idiot giving advice to people that are dumber than you fuck off
 






Why insult The Grinder when none of my posts are abusive. I show compassion for everyone in this difficult situation.

I understand you are under stress so I forgive you for what you wrote.

Have a good night
 
























If these are sales reps bashing the good old WS Grinder than it explains a lot about lack of sales.

Again, the majority of sales reps are good hard working farmers and hunters that help Pernix drive revenue. But some of these abusive sales reps on this board blame everyone but themselves for issues.

Again, I forgive all of you as you do not know what your are doing by bashing Grinder.
 






Wall Street Grinder said:
If these are sales reps bashing the good old WS Grinder than it explains a lot about lack of sales.

Again, the majority of sales reps are good hard working farmers and hunters that help Pernix drive revenue. But some of these abusive sales reps on this board blame everyone but themselves for issues.

Again, I forgive all of you as you do not know what your are doing by bashing Grinder.
Click to expand...
Forgive them Father (Grinder) for they know not what they do
 












Top Bottom
Back
Quote